[1] Vancampfort D,Correll CU,Wampers M,et al. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder:a meta-analysis of prevalences and moderating variables[J].Psychol Med,2014,44(10):2017-2028. [2] Sharma AN, Ligade SS, Sharma JN. et al. GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats[J].Metab Brain Dis,2015,30(2):519-527. [3] 李东风,章秋,刘桂,等.精神分裂症与代谢综合征的相关性研究[J].中国全科医学,2014,17(34):4083-4086. [4] 谭庆荣.精神分裂症伴发代谢综合征的处理[J].中华精神科杂志,2014,47(3):172-173. [5] Babizhayev MA. Biochemical, biomedical and metabolic aspects of imidazole-containing dipeptides with the inherent complexity to neurodegenerative diseases and various states of mental well-being: a challenging correction and neurotherapeutic pharmaceutical biotechnology for treating cognitive deficits, depression and intellectual disabilities[J].Curr Pharm Biotechnol,2014,15(8):738-778. [6] McElroy SL, Keck PE Jr. Metabolic syndrome in bipolar disorder: A review with a focus on bipolar depression[J].J Clin Psychiatry,2014,75(1):46-61. [7] 柏林,张国玲,高淑英,等.常用非典型抗精神病药物与首发精神分裂症患者代谢综合征的相关性研究[J].河北医学,2015,21(1):151-154. [8] 季春英,孙莲芳,翁英,等.非典型抗精神病药物所致代谢综合征干预措施的研究进展[J].中国实用护理杂志,2014,30(35):51-53. [9] 戴升太,朱立毛,肖依烂,等.二甲双胍对抗精神病药所致精神分裂症患者肥胖及糖脂代谢的影响[J].临床精神医学杂志,2014,24(6):409-410. [10] 苏文君,职晓松,张懿,等.抑郁症与代谢综合征的神经内分泌免疫联系[J].现代生物医学进展,2017,17(11):2190-2193. [11] 梅力,易正辉.精神分裂症伴发代谢综合征的防治研究进展[J].中国神经精神疾病杂志,2014,40(7):443-446. [12] 汤亚雨,张宁,贾坚,等.老年代谢综合征患者合并焦虑抑郁状况及影响因素分析[J].中华全科医师杂志,2017,16(6):453-456. (本文编辑:张兴珍) [收稿日期] 2017-07-20
2017, Vol. 34 
